Requiring the Maryland Insurance Administration and the Maryland Department of Health, in consultation with the Prescription Drug Affordability Board, to convene a workgroup to study and review reimbursement for pharmacists; and requiring the workgroup to submit an interim report by December 31, 2025, and a final report on their findings and recommendations to certain committees of the General Assembly by December 31, 2026.